<div class="welcome-screen" id="welcomeScreen">
    <div class="welcome-banner">
        <h1 id="welcome-title">Welcome to the polyneuropathy page!</h1>
        <p id="welcome-description">Explore the following topics to enhance your knowledge.</p>
    </div>
    
    <div class="explanation-card">
        <h1>Introduction to Neuropathies</h1>
        <h2>Anatomy of Peripheral Nerves</h2>
        <p><b>Peripheral nerves</b> are composed of axons, Schwann cells, connective tissue, and blood vessels. The <b>endoneurium</b> surrounds individual axons, the <b>perineurium</b> bundles axons into fascicles, and the <b>epineurium</b> encases the entire nerve. <b>Myelinated fibers</b> are ensheathed by Schwann cells, which produce myelin, whereas <b>unmyelinated fibers</b> are embedded within Schwann cells without concentric wrapping.</p>
        
        <img src="Images/image_nerve_bundle.jpg">

        <h2>Histology and Physiology</h2>
        <p><b>Motor neurons</b> have cell bodies in the anterior horn of the spinal cord, while <b>sensory neurons</b> reside in the dorsal root ganglia. <b>Autonomic fibers</b> (sympathetic and parasympathetic) originate from the intermediolateral column and autonomic ganglia. Nerve conduction depends on <b>ion channels</b> (Na⁺, K⁺) and myelin integrity. Demyelination slows conduction velocity, whereas axonal degeneration reduces signal amplitude.</p>
        
        <h2>Pathophysiological Mechanisms</h2>
        <p>Neuropathies arise from <b>axonal degeneration</b> (e.g., diabetes), <b>demyelination</b> (e.g., Guillain-Barré syndrome), or <b>neuronopathy</b> (e.g., sensory neuronopathy in Sjögren’s). Common mechanisms include <b>ischemia</b>, <b>metabolic dysfunction</b>, <b>immune-mediated attack</b>, and <b>toxin accumulation</b>.</p>
        
        <h2>Historical Context</h2>
        <p>The term <b>"neuropathy"</b> was coined in the 19th century, but descriptions of peripheral nerve disorders date back to ancient Egypt. Landmark discoveries include <b>Guillain, Barré, and Strohl’s</b> 1916 report on acute inflammatory demyelinating polyneuropathy and <b>Charcot-Marie-Tooth’s</b> 1886 description of hereditary motor-sensory neuropathy.</p>
    </div>

    <div class="question-card">
        <h1>Question 1</h1>
        <p>Which structure encases the entire peripheral nerve?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Endoneurium</li>
            <li data-answer="wrong">Perineurium</li>
            <li data-answer="correct">Epineurium</li>
        </ul>
    </div>

    <div class="question-card">
        <h1>Question 2</h1>
        <p>What is the primary physiological consequence of demyelination?</p>
        <ul class="options" id="options">
            <li data-answer="correct">Slowed conduction velocity</li>
            <li data-answer="wrong">Reduced signal amplitude</li>
            <li data-answer="wrong">Complete conduction block</li>
        </ul>
    </div>

    <div class="explanation-card">
        <h1>Inflammatory Neuropathy: Guillain-Barré Syndrome (GBS)</h1>
        <h2>Aetiology</h2>
        <p>GBS is an <b>immune-mediated</b> disorder, often triggered by preceding infections (e.g., <i>Campylobacter jejuni</i>, CMV, EBV, or <i>Mycoplasma pneumoniae</i>). Molecular mimicry between microbial antigens (e.g., gangliosides GM1, GD1a) and peripheral nerve components drives <b>autoantibody production</b>.</p>
        
        <h2>Epidemiology and Risk Factors</h2>
        <p>GBS has an incidence of <b>1–2/100,000/year</b>, with a slight male predominance. Risk factors include recent <b>gastroenteritis</b> (especially <i>C. jejuni</i>), <b>vaccinations</b> (e.g., influenza), and <b>surgery</b>.</p>
        
        <h2>Pathophysiology</h2>
        <p>Autoantibodies target <b>myelin</b> (acute inflammatory demyelinating polyneuropathy, AIDP) or <b>axonal membranes</b> (acute motor axonal neuropathy, AMAN). Complement activation leads to <b>macrophage infiltration</b>, myelin stripping, and conduction block.</p>
        
        <h2>Symptoms</h2>
        <p><b>Ascending paralysis</b> begins distally (e.g., foot weakness) and progresses proximally. <b>Autonomic dysfunction</b> (e.g., labile blood pressure, arrhythmias) and <b>sensory symptoms</b> (e.g., paresthesias) are common. <b>Respiratory failure</b> occurs in 25% due to diaphragm weakness.</p>
        
        <div class="mnemonic">
            <p><b>Mnemonic: "GBS RISES"</b> – <b>G</b>ait difficulty, <b>B</b>ilateral weakness, <b>S</b>ensory loss, <b>R</b>eflex loss, <b>I</b>nfection preceding, <b>S</b>ymmetric, <b>E</b>levated CSF protein, <b>S</b>low conduction velocity.</p>
        </div>
        
        <h2>Diagnosis</h2>
        <p><b>Clinical criteria</b> include progressive weakness in ≥2 limbs and areflexia. <b>CSF analysis</b> shows albuminocytologic dissociation (high protein, normal WBCs). <b>Electrodiagnostic studies</b> reveal prolonged distal latencies and conduction block.</p>
        
        <h2>Treatment</h2>
        <p><b>IV immunoglobulin</b> (2 g/kg over 5 days) or <b>plasmapheresis</b> is first-line. Supportive care (e.g., mechanical ventilation for respiratory failure) is critical. <b>Corticosteroids are ineffective</b>.</p>
        
        <h2>Complications</h2>
        <p><b>Respiratory failure</b>, <b>dysautonomia</b>, <b>venous thromboembolism</b>, and <b>chronic fatigue</b>. <b>10% of patients die</b>, and 20% have permanent disability.</p>
    </div>

    <div class="question-card">
        <h1>Question 3</h1>
        <p>Which infectious trigger of GBS is most strongly associated with axonal variants?</p>
        <ul class="options" id="options">
            <li data-answer="correct">Campylobacter jejuni</li>
            <li data-answer="wrong">Epstein-Barr virus</li>
            <li data-answer="wrong">Mycoplasma pneumoniae</li>
        </ul>
    </div>

    <div class="question-card">
        <h1>Question 4</h1>
        <p>What is the hallmark CSF finding in GBS?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Pleocytosis</li>
            <li data-answer="correct">Albuminocytologic dissociation</li>
            <li data-answer="wrong">Low glucose</li>
        </ul>
    </div>

    <div class="explanation-card">
        <h1>Polyneuropathies</h1>
        <h2>Diabetic Polyneuropathy</h2>
        <p><b>Aetiology:</b> Chronic hyperglycemia leads to <b>advanced glycation end-products (AGEs)</b>, oxidative stress, and microvascular ischemia. <b>Axonal degeneration</b> predominates, affecting longest nerves first ("length-dependent").</p>
        <p><b>Symptoms:</b> <b>Distal symmetric sensory loss</b> ("stocking-glove"), <b>neuropathic pain</b> (burning, lancinating), and <b>autonomic dysfunction</b> (gastroparesis, erectile dysfunction).</p>
        <p><b>Treatment:</b> Tight glycemic control, <b>pregabalin/gabapentin</b> for pain, and <b>TCAs/SNRIs</b> (e.g., amitriptyline, duloxetine).</p>
        
        <div class="mnemonic">
            <p><b>Mnemonic: "DIABETES"</b> – <b>D</b>istal symmetric, <b>I</b>nsidious onset, <b>A</b>xonal, <b>B</b>urning pain, <b>E</b>levated glucose, <b>T</b>emperature insensitivity, <b>E</b>arly autonomic signs, <b>S</b>low progression.</p>
        </div>
        
        <h2>Thiamine Deficiency (Beri-Beri)</h2>
        <p><b>Aetiology:</b> Thiamine (vitamin B1) deficiency impairs <b>ATP production</b> (Krebs cycle dysfunction). Common in alcoholism, malnutrition, or bariatric surgery.</p>
        <p><b>Symptoms:</b> <b>Wet beri-beri</b> (high-output cardiac failure) and <b>dry beri-beri</b> (neuropathy: painful paresthesias, weakness). <b>Wernicke’s encephalopathy</b> (ataxia, ophthalmoplegia, confusion) may coexist.</p>
        <p><b>Treatment:</b> High-dose <b>IV thiamine</b> (500 mg TID), then oral maintenance.</p>
        
        <h2>Charcot-Marie-Tooth Disease (CMT)</h2>
        <p><b>Aetiology:</b> Inherited mutations (e.g., <b>PMP22 duplication</b> in CMT1A) cause <b>demyelination</b> (CMT1) or <b>axonal loss</b> (CMT2).</p>
        <p><b>Symptoms:</b> <b>Distal wasting</b> ("inverted champagne bottle" legs), <b>foot deformities</b> (pes cavus), and <b>steppage gait</b>.</p>
        <p><b>Treatment:</b> Supportive (orthotics, physical therapy). <b>No disease-modifying therapy exists</b>.</p>
    </div>

    <div class="question-card">
        <h1>Question 5</h1>
        <p>Which feature is most characteristic of diabetic polyneuropathy?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Proximal muscle weakness</li>
            <li data-answer="correct">Stocking-glove sensory loss</li>
            <li data-answer="wrong">Cranial nerve involvement</li>
        </ul>
    </div>

    <div class="question-card">
        <h1>Question 6</h1>
        <p>What is the first-line treatment for thiamine deficiency neuropathy?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Oral folate</li>
            <li data-answer="correct">IV thiamine</li>
            <li data-answer="wrong">Vitamin B12 injections</li>
        </ul>
    </div>

    <div class="placeholder" id="empty">Test</div>

</div>